Healthcare provider profile · identity verified

Alfredo Lim, M.D.

Internal Medicine · PHOENIX, AZ · NPI 1225002371

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	784	223
Levothyroxine Sodium	Levothyroxine Sodium	613	168
Amlodipine Besylate	Amlodipine Besylate	522	149
Metformin Hcl	Metformin Hcl	412	116
Lisinopril	Lisinopril	354	104
Losartan Potassium	Losartan Potassium	349	100
Carvedilol	Carvedilol	259	61
Rosuvastatin Calcium	Rosuvastatin Calcium	254	69
Pantoprazole Sodium	Pantoprazole Sodium	237	70
Pravastatin Sodium	Pravastatin Sodium	230	71
Omeprazole	Omeprazole	226	64
Gabapentin	Gabapentin	224	52
Albuterol Sulfate Hfa	Albuterol Sulfate	214	95
Escitalopram Oxalate	Escitalopram Oxalate	207	46
Metoprolol Tartrate	Metoprolol Tartrate	205	55
Tamsulosin Hcl	Tamsulosin Hcl	205	53
Allopurinol	Allopurinol	198	52
Zolpidem Tartrate	Zolpidem Tartrate	180	36
Jardiance	Empagliflozin	164	35
Ozempic	Semaglutide	159	27
Metoprolol Succinate	Metoprolol Succinate	149	45
Simvastatin	Simvastatin	146	39
Pioglitazone Hcl	Pioglitazone Hcl	137	35
Eliquis	Apixaban	134	31
Hydrochlorothiazide	Hydrochlorothiazide	134	46
Sertraline Hcl	Sertraline Hcl	134	40
Alendronate Sodium	Alendronate Sodium	131	28
Trazodone Hcl	Trazodone Hcl	124	26
Furosemide	Furosemide	101	27
Olmesartan Medoxomil	Olmesartan Medoxomil	98	30
Clopidogrel	Clopidogrel Bisulfate	94	30
Potassium Chloride	Potassium Chloride	88	26
Glimepiride	Glimepiride	86	24
Montelukast Sodium	Montelukast Sodium	86	26
Duloxetine Hcl	Duloxetine Hcl	75	15
Irbesartan	Irbesartan	70	21
Farxiga	Dapagliflozin Propanediol	69	16
Mirtazapine	Mirtazapine	66	15
Clonazepam	Clonazepam	64	suppressed
Xarelto	Rivaroxaban	64	12
Tradjenta	Linagliptin	61	suppressed
Atenolol	Atenolol	60	17
Felodipine Er	Felodipine	59	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	58	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	58	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	14
Alprazolam	Alprazolam	57	16
Doxazosin Mesylate	Doxazosin Mesylate	57	17
Tresiba Flextouch U-100	Insulin Degludec	56	suppressed
Prednisone	Prednisone	53	27
Tramadol Hcl	Tramadol Hcl	51	13
Hydralazine Hcl	Hydralazine Hcl	50	14
Terazosin Hcl	Terazosin Hcl	50	15
Azithromycin	Azithromycin	49	45
Ezetimibe	Ezetimibe	49	14
Finasteride	Finasteride	49	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	14
Fenofibrate	Fenofibrate	48	12
Telmisartan	Telmisartan	48	11
Synthroid	Levothyroxine Sodium	46	13
Venlafaxine Hcl Er	Venlafaxine Hcl	42	11
Paroxetine Hcl	Paroxetine Hcl	41	suppressed
Famotidine	Famotidine	40	13
Lovastatin	Lovastatin	40	12
Januvia	Sitagliptin Phosphate	38	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	suppressed
Nifedipine Er	Nifedipine	38	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	11
Pregabalin	Pregabalin	36	suppressed
Tizanidine Hcl	Tizanidine Hcl	36	suppressed
Estradiol	Estradiol	35	suppressed
Lorazepam	Lorazepam	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Bupropion Hcl Sr	Bupropion Hcl	33	12
Cefdinir	Cefdinir	32	32
Donepezil Hcl	Donepezil Hcl	32	suppressed
Fluticasone Propionate	Fluticasone Propionate	32	18
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Warfarin Sodium	Warfarin Sodium	31	suppressed
Bumetanide	Bumetanide	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	18
Ondansetron Hcl	Ondansetron Hcl	29	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	11
Venlafaxine Hcl	Venlafaxine Hcl	29	suppressed
Benazepril Hcl	Benazepril Hcl	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Meloxicam	Meloxicam	27	suppressed
Metformin Hcl Er	Metformin Hcl	27	suppressed
Carisoprodol	Carisoprodol	26	suppressed
Doxepin Hcl	Doxepin Hcl	26	suppressed
Sucralfate	Sucralfate	26	suppressed
Cephalexin	Cephalexin	25	22
Doxycycline Hyclate	Doxycycline Hyclate	25	23
Temazepam	Temazepam	25	suppressed
Linzess	Linaclotide	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	21
Paxlovid	Nirmatrelvir/Ritonavir	23	22
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Cefuroxime	Cefuroxime Axetil	21	20
Naproxen	Naproxen	21	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	20	suppressed
Valsartan	Valsartan	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Calcitriol	Calcitriol	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Gemfibrozil	Gemfibrozil	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Rizatriptan	Rizatriptan Benzoate	19	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Acyclovir	Acyclovir	18	13
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Levemir Flexpen	Insulin Detemir	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Risedronate Sodium	Risedronate Sodium	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Nebivolol Hcl	Nebivolol Hcl	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Xtampza Er	Oxycodone Myristate	16	suppressed
Fluconazole	Fluconazole	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Humalog Junior Kwikpen	Insulin Lispro	15	suppressed
Premarin	Estrogens, Conjugated	15	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Indomethacin	Indomethacin	13	suppressed
Topiramate	Topiramate	13	suppressed
Bydureon Bcise	Exenatide Microspheres	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Ramipril	Ramipril	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Colchicine	Colchicine	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error